Head to Head Survey: Globe Life (GL) vs. Its Rivals

Globe Life (NYSE:GL – Get Free Report) is one of 311 publicly-traded companies in the “Insurance” industry, but how does it compare to its rivals? We will compare Globe Life to similar companies based on the strength of its earnings, institutional ownership, analyst recommendations, profitability, valuation, risk and dividends.

Volatility & Risk

Globe Life has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Comparatively, Globe Life’s rivals have a beta of -1.59, meaning that their average share price is 259% less volatile than the S&P 500.

Dividends

Globe Life pays an annual dividend of $1.32 per share and has a dividend yield of 0.8%. Globe Life pays out 8.8% of its earnings in the form of a dividend. As a group, “Insurance” companies pay a dividend yield of 2.9% and pay out 31.1% of their earnings in the form of a dividend. Globe Life has raised its dividend for 20 consecutive years.

Analyst Recommendations

This is a breakdown of recent ratings for Globe Life and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Globe Life 0 3 7 2 2.92
Globe Life Competitors 3350 15721 16570 747 2.40

Globe Life presently has a consensus price target of $183.91, indicating a potential upside of 14.55%. As a group, “Insurance” companies have a potential upside of 4.22%. Given Globe Life’s stronger consensus rating and higher possible upside, analysts clearly believe Globe Life is more favorable than its rivals.

Insider & Institutional Ownership

81.6% of Globe Life shares are owned by institutional investors. Comparatively, 55.8% of shares of all “Insurance” companies are owned by institutional investors. 2.1% of Globe Life shares are owned by insiders. Comparatively, 13.5% of shares of all “Insurance” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Globe Life and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Globe Life 18.89% 19.51% 3.91%
Globe Life Competitors 9.46% -10.06% 4.09%

Earnings & Valuation

This table compares Globe Life and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Globe Life $5.99 billion $1.16 billion 10.74
Globe Life Competitors $15.06 billion $1.70 billion 33.69

Globe Life’s rivals have higher revenue and earnings than Globe Life. Globe Life is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Globe Life beats its rivals on 9 of the 15 factors compared.

About Globe Life

(Get Free Report)

Globe Life Inc. is a U.S.-based insurance holding company that provides life and supplemental health insurance through its subsidiaries. Its products include term and whole life insurance, Medicare Supplement insurance, and supplemental health coverage such as accident, cancer, and critical illness policies. The company distributes insurance through a mix of exclusive agents, independent agents, and direct marketing. Its operating companies include Globe Life and Accident Insurance Company, American Income Life, Liberty National, Family Heritage Life, and United American.

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.